Inducers of Friend leukaemic cell differentiation in vitro--effects of in vivo administration.
Studies were conducted of the in vivo therapeutic potential of compounds which induce the differentiation of Friend leukaemia cells (FLC) in vitro. DBA2/J mice were inoculated with Friend leukaemia cells grown in tissue culture and at various times thereafter were treated with either N-methylacetamide, dimethylacetamide, or tetramethylurea. While survival was only occasionally prolonged, in every study these agents significantly inhibited leukaemia cell proliferation in the spleen and to a lesser extent in the marrow. These agents had no effect on the rate of proliferation of FLC growing subcutaneously nor on the proliferation of myeloid leukaemia in RFMS mice. These studies indicate that the administration of inducing agents to mice bearing Friend leukaemia can alter the proliferation characteristics of the leukaemia cells and hence suggest that these agents may have therapeutic potential.
D000081:Acetamides / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D002460:Cell Line; D002999:Clone Cells; D004920:Erythropoiesis; D005622:Friend murine leukemia virus; D007942:Leukemia, Experimental / Q000188:drug therapy*; D008297:Male; D008782:Methylurea Compounds / Q000494:pharmacology / Q000627:therapeutic use*; D051379:Mice; D013154:Spleen / Q000187:drug effects; D013163:Splenomegaly / Q000139:chemically induced
D000081:Acetamides; D008782:Methylurea Compounds